Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hyperlipidaemia
ADR ID BADD_A06050
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
14.08.03      Hyperlipidaemias NEC
14.08.03.001      Hyperlipidaemia
Description Conditions with excess LIPIDS in the blood. | Abnormally high level of lipids in blood. [MeSH]
MedDRA Code 10062060
MeSH ID D006949; D006951
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Hyperlipaemia | Hyperlipemia | Hyperlipidaemia NOS | Hyperlipidaemia secondary | Hyperlipidaemia, other and unspecified | Hyperlipidemia | Hyperlipoproteinemia | Other and unspecified hyperlipidaemia | Other and unspecified hyperlipidemia | Hyperlipidemia secondary | Hyperlipoproteinaemia | Hyperlipidaemia | Lipemia | Lipaemia | Hyperlipidemias | Hyperlipemias | Lipidemia | Lipidemias | Lipemias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02151Temsirolimus--
BADD_D02154Tenofovir0.001939%
BADD_D02170Testosterone0.000591%
BADD_D02174Testosterone undecanoate--
BADD_D02192Thalidomide--
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02226Tipranavir--
BADD_D02227Tipranavir disodium--
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02236Tofacitinib0.015431%
BADD_D02247Topiramate--
BADD_D02254Tramadol--
BADD_D02259Trandolapril--
BADD_D02270Tretinoin--
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000106%
BADD_D02337Varenicline0.000195%
BADD_D02338Varenicline tartrate--
BADD_D02346Venlafaxine--
BADD_D02378Zalcitabine--
BADD_D02389Ziprasidone hydrochloride--
BADD_D02391Ziprasidone mesylate--
BADD_D02394Zolpidem--
BADD_D02395Zolpidem tartrate--
BADD_D02398Zuclopenthixol--
BADD_D02504Lorlatinib0.004533%
BADD_D02588Remdesivir0.000565%
BADD_D02615Bilastine--
The 5th Page    First    Pre   5    Total 5 Pages